MarketInOut Stock Screener Log In | Sign Up

Bukwang Pharmaceutical Co Ltd

KRX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:30
Bukwang Pharmaceutical Co Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization386,766 mln
Float67.88 mln
Earnings Date07/23/2025

EPS

88.97
Exceptional

P / E

42.17
High premium

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-1.38
Manipulation likely

Relative Strength

58 / 100
Slightly ahead

Debt / Equity

0.24
Very low leverage

Business Description

Founded in 1960 and based in Seoul, Bukwang Pharmaceutical is a South Korean drug maker that sells a wide range of prescription medicines, over-the-counter products, and everyday health items such as vitamins, oral care goods, and dietary supplements, both at home and abroad. The company serves patients across many medical fields, from heart disease and cancer to digestive and mental health conditions. It is also advancing a pipeline of new treatments targeting schizophrenia, Parkinson's disease, prostate cancer, and other serious illnesses.

Key Fundamentals

EPS88.97
P/E42.17
ROE2.75
RPS2,200
ROIC4.27
ROA1.92
Interest Cover2.05
EBITDA, mln18,954
EV / EBITDA16.27
EV / EBIT22.28
Revenue, mln215,093
EV / Revenue1.43

Quote Details

Last 3,750.00
Change -5 (-0.13%)
Open 3,780.00
Volume 216,703
Turnover 812,636,224
Average Volume 376,253

Financial Ratios

Pre-Tax Profit Margin4
Leverage Ratio1.40
Current Ratio2.33
Price / Book1.19
Price / Tangible Book1.21
Price / Cash Flow113
Debt / Equity0.24
Price / Sales1.84

Financial Strength

Altman Z-Score3.25
Piotroski F-Score 4 / 9
Beneish M-Score-1.38
Price to Intrinsic Value1.05
Price to Graham Number1.56
Shiller PE Ratio23.16

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.6% 34 / 100   
1 Month -4.58% 57 / 100   
2 Months -3.97% 52 / 100   
6 Months -48.56% 15 / 100   
1 Year 5.16% 70 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog